AR055927A1 - Sistema terapeutico transdermico solido con absorbedor uv - Google Patents
Sistema terapeutico transdermico solido con absorbedor uvInfo
- Publication number
- AR055927A1 AR055927A1 ARP060101711A ARP060101711A AR055927A1 AR 055927 A1 AR055927 A1 AR 055927A1 AR P060101711 A ARP060101711 A AR P060101711A AR P060101711 A ARP060101711 A AR P060101711A AR 055927 A1 AR055927 A1 AR 055927A1
- Authority
- AR
- Argentina
- Prior art keywords
- therapeutic system
- transdermal therapeutic
- active substance
- matrix containing
- containing active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Sistema terapéutico transdérmico solido con absorbedor UV disenado especialmente para sustancias activas farmacéuticas sensible a la luz. El sistema terapéutico transdérmico (STT) estable a los rayos UV comprende una chapa de base 1, al menos una matriz que contiene sustancia activa 2 y una película protectora desprendible 3, donde opcionalmente se puede intercalar una capa adhesiva 4 y una capa separadora 5 entre la capa de base 1 y la matriz que contiene sustancia activa 2. En la capa de base 1 o en la matriz que contiene sustancia activa 2 o en la capa adhesiva 4 se pueden incluir absorbedores UV del grupo de las hidroxifeniltriazinas. El STT de la presente estabilidad con baja concentracion de absorbedores UV. Con ello se puede evitar o reducir el riesgo de una posible irritacion cutánea.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05009579A EP1719504A1 (de) | 2005-05-02 | 2005-05-02 | Festes transdermales therapeutisches System mit UV-Absorber |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR055927A1 true AR055927A1 (es) | 2007-09-12 |
Family
ID=34981458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060101711A AR055927A1 (es) | 2005-05-02 | 2006-04-28 | Sistema terapeutico transdermico solido con absorbedor uv |
Country Status (26)
| Country | Link |
|---|---|
| EP (2) | EP1719504A1 (es) |
| JP (2) | JP5360877B2 (es) |
| KR (2) | KR101426218B1 (es) |
| CN (2) | CN108969507A (es) |
| AR (1) | AR055927A1 (es) |
| AU (1) | AU2006243442A1 (es) |
| BR (1) | BRPI0611087A2 (es) |
| CA (1) | CA2605112C (es) |
| CR (1) | CR9483A (es) |
| CY (1) | CY1115757T1 (es) |
| DK (1) | DK1879560T3 (es) |
| DO (1) | DOP2006000100A (es) |
| EA (1) | EA200702344A1 (es) |
| ES (1) | ES2523663T3 (es) |
| GT (1) | GT200600183A (es) |
| IL (1) | IL186945A0 (es) |
| MX (1) | MX2007013779A (es) |
| NO (1) | NO20076187L (es) |
| PE (1) | PE20061414A1 (es) |
| PL (1) | PL1879560T3 (es) |
| PT (1) | PT1879560E (es) |
| SI (1) | SI1879560T1 (es) |
| TW (1) | TW200719902A (es) |
| UY (1) | UY29511A1 (es) |
| WO (1) | WO2006117139A2 (es) |
| ZA (1) | ZA200710418B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1594483B1 (de) | 2003-02-21 | 2006-07-19 | Schering AG | Uv-stabiles transdermales pflaster |
| US8668925B2 (en) | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
| US8962013B2 (en) | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
| LT2613772T (lt) * | 2010-09-06 | 2017-03-27 | Bayer Intellectual Property Gmbh | Mažos dozės transderminiai pleistrai, pasižymintys aktyviu vaisto atpalaidavimu |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023084A (en) * | 1986-12-29 | 1991-06-11 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
| EP0453396B1 (de) * | 1990-03-30 | 1995-12-13 | Ciba SC Holding AG | Lackzusammensetzungen |
| US8173592B1 (en) * | 1999-03-31 | 2012-05-08 | Zentaris Ivf Gmbh | Method for a programmed controlled ovarian stimulation protocol |
| US7384650B2 (en) * | 1999-11-24 | 2008-06-10 | Agile Therapeutics, Inc. | Skin permeation enhancement composition for transdermal hormone delivery system |
| US6924410B2 (en) * | 2000-03-17 | 2005-08-02 | Hisamitsu Pharmaceutical Co., Ltd. | Ultraviolet-screening patch |
| EP1452173A1 (de) * | 2003-02-25 | 2004-09-01 | Schering AG | UV-stabiles transdermales Pflaster |
| EP1594483B1 (de) | 2003-02-21 | 2006-07-19 | Schering AG | Uv-stabiles transdermales pflaster |
| EP1664128B1 (en) * | 2003-09-11 | 2009-01-21 | Ciba Holding Inc. | Water based concentrated product forms of light stabilizers made by a heterophase polymerization technique |
-
2005
- 2005-05-02 EP EP05009579A patent/EP1719504A1/de not_active Withdrawn
-
2006
- 2006-04-28 MX MX2007013779A patent/MX2007013779A/es not_active Application Discontinuation
- 2006-04-28 ES ES06753441.2T patent/ES2523663T3/es active Active
- 2006-04-28 AR ARP060101711A patent/AR055927A1/es not_active Application Discontinuation
- 2006-04-28 DO DO2006000100A patent/DOP2006000100A/es unknown
- 2006-04-28 WO PCT/EP2006/003959 patent/WO2006117139A2/de active Application Filing
- 2006-04-28 DK DK06753441.2T patent/DK1879560T3/en active
- 2006-04-28 KR KR1020137019206A patent/KR101426218B1/ko active IP Right Grant
- 2006-04-28 AU AU2006243442A patent/AU2006243442A1/en not_active Abandoned
- 2006-04-28 PE PE2006000451A patent/PE20061414A1/es not_active Application Discontinuation
- 2006-04-28 JP JP2008509340A patent/JP5360877B2/ja not_active Expired - Fee Related
- 2006-04-28 CN CN201810889234.4A patent/CN108969507A/zh not_active Withdrawn
- 2006-04-28 EA EA200702344A patent/EA200702344A1/ru unknown
- 2006-04-28 UY UY29511A patent/UY29511A1/es not_active Application Discontinuation
- 2006-04-28 EP EP06753441.2A patent/EP1879560B1/de active Active
- 2006-04-28 SI SI200631854T patent/SI1879560T1/sl unknown
- 2006-04-28 CA CA2605112A patent/CA2605112C/en not_active Expired - Fee Related
- 2006-04-28 PL PL06753441T patent/PL1879560T3/pl unknown
- 2006-04-28 GT GT200600183A patent/GT200600183A/es unknown
- 2006-04-28 CN CNA2006800151185A patent/CN101171001A/zh active Pending
- 2006-04-28 KR KR1020077025388A patent/KR101351161B1/ko active IP Right Grant
- 2006-04-28 PT PT67534412T patent/PT1879560E/pt unknown
- 2006-04-28 BR BRPI0611087-8A patent/BRPI0611087A2/pt not_active Application Discontinuation
- 2006-05-02 TW TW095115581A patent/TW200719902A/zh unknown
-
2007
- 2007-10-25 IL IL186945A patent/IL186945A0/en unknown
- 2007-10-30 CR CR9483A patent/CR9483A/es not_active Application Discontinuation
- 2007-11-30 ZA ZA200710418A patent/ZA200710418B/xx unknown
- 2007-11-30 NO NO20076187A patent/NO20076187L/no not_active Application Discontinuation
-
2013
- 2013-06-12 JP JP2013123885A patent/JP2013177451A/ja not_active Withdrawn
-
2014
- 2014-11-13 CY CY20141100949T patent/CY1115757T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28189A1 (es) | Sistema terapéutico transdérmico estable a los rayos uv. | |
| ES2581574T3 (es) | Sistema terapéutico transdérmico para la administración del principio activo buprenorfina | |
| AR097045A2 (es) | Sistema terapéutico transdérmico | |
| AR073704A1 (es) | Sistema de administracion transdermal de droga para principios activos liquidos que tiene una capa de matriz adhesiva que incluye un ingrediente farmaceutico activo que es seleccionado entre selegilina y rivastigmina | |
| AR062772A1 (es) | Aposito de pelicula delgada | |
| AR070031A1 (es) | Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas | |
| PE20070312A1 (es) | Estuche para alojar un envase con medicamento | |
| AR055927A1 (es) | Sistema terapeutico transdermico solido con absorbedor uv | |
| BR0313091A (pt) | Sistema de liberação transdérmica aperfeiçoado para a administração de rotigotina | |
| AR033748A1 (es) | Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo | |
| CY1108069T1 (el) | Φαρμακευτικη συνθεση σε μορφη υδρογελης για διαδερμικη χορηγηση δραστικων ουσιων | |
| AR054012A1 (es) | Sistema terapeutico transdermico para la adminstracion de analgesicos | |
| BR0313092A (pt) | Sistema de liberação transdérmica aperfeiçoado | |
| AR028525A1 (es) | Sistema terapeutico transdermal para la administracion de lerisetron | |
| CR8461A (es) | Forma de administracion transdermica, liquida o semisolida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletas | |
| BRPI0520821A2 (pt) | formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada | |
| BRPI0603538A (pt) | preparações farmacêuticas do tipo para absorção percutánea | |
| ITMI20020798A1 (it) | Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici | |
| AR044939A1 (es) | Sistema de administracion para medicaciones topicas | |
| CU23518A3 (es) | Sistema terapéutico transdérmico estable a los rayos ultravioletas | |
| CO5640059A2 (es) | Uso de clorofila para el control de malos olores en articulos absorbentes desechables | |
| TH87440A (th) | ระบบรักษาโรคผ่านทางผิวหนังชนิดของแข็งที่มีสารดูดกลืนยูวี | |
| AR041539A1 (es) | Dispositivo de liberacion transdermal para l a administracion de fentanilo | |
| AR093675A1 (es) | Un dispositivo para la administracion transdermica de rotigotina | |
| AR082906A1 (es) | Parches transdermicos de dosis baja con nivel elevado de liberacion de droga |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |